샘플 요청 목록

 카트 문의
시장보고서
상품코드
1788207

비침습적 관상동맥 이미징 시장

Non-invasive Coronary Imaging
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 274 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 비침습적 관상동맥 이미징 시장은 2030년까지 5억 3,060만 달러에 달할 전망

2024년에 3억 9,230만 달러로 추정되는 세계의 비침습적 관상동맥 이미징 시장은 2030년에는 5억 3,060만 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 5.2%로 성장할 것으로 예측됩니다. 이 리포트에서 분석하고 있는 부문의 하나인 심장 초음파 검사는 CAGR 3.5%를 기록하며, 분석 기간 종료시에는 2억 480만 달러에 달할 것으로 예측됩니다. 심장 컴퓨터 단층촬영의 성장률은 분석 기간 중 CAGR 6.6%로 추정됩니다.

미국 시장은 1억 690만 달러로 추정, 중국은 CAGR 7.9%로 성장 예측

미국의 비침습적 관상동맥 이미징 시장은 2024년에 1억 690만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 1억 400만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 7.9%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.6%와 5.0%로 예측됩니다. 유럽에서는 독일이 CAGR 3.3%로 성장할 것으로 예측됩니다.

세계의 비침습적 관상동맥 이미징 시장 - 주요 동향과 촉진요인 정리

비침습적 관상동맥 이미징이 심혈관 진단의 판도를 어떻게 바꿀 것인가?

비침습적 관상동맥 이미징은 카테터를 이용한 시술 없이도 안전하고 신속하며 정확한 관상동맥질환(CAD) 평가 방법을 임상의에게 제공함으로써 심혈관 진단의 전망에 혁명을 불러일으키고 있습니다. 기존의 관상동맥 조영술은 효과적이지만 침습적 특성으로 인해 잠재적인 혈관 손상, 조영제에 대한 알레르기 반응, 검사 후 회복 시간 등 환자 위험성이 큽니다. 반면, 관상동맥 컴퓨터단층촬영(CCTA), 심장 자기공명영상(CMR), 양전자방사단층촬영(PET) 등의 비침습적 기술은 관상동맥 혈관의 고해상도 시각화를 가능케 하면서도 시술의 위험성을 낮추고 있습니다. 이러한 기술은 플라크 축적을 감지하고, 협착을 평가하고, 전반적인 심장 기능을 평가하는 데 매우 중요한 역할을 하고 있습니다. 환자 입장에서는 검사 시간 단축, 불편감 감소, 입원 기간 단축 등의 큰 이점이 있으며, 의사 입장에서는 상세한 해부학적, 기능적 데이터에 대한 접근을 통해 더 많은 정보에 기반한 치료 방침을 결정할 수 있습니다. 또한 비침습적 영상 진단 툴은 증상이 나타나기 훨씬 전에 잠재적인 죽상동맥경화증을 감지할 수 있으며, 예방적 심장병학에서 필수적인 역할을 하고 있습니다. CT에서 얻은 분획혈류예비력(FFR-CT)과 같은 방법을 통한 기능적 평가의 통합은 해부학적 영상과 생리적 인사이트 사이의 간극을 메워 허혈을 유발하는 병변을 보다 정확하게 식별할 수 있게 해줍니다. 심혈관계 질환이 여전히 전 세계 사망원인 1위인 만큼, 조기 발견과 질병 관리에 있으며, 비침습적 영상 진단의 역할은 앞으로 더욱 커질 것으로 예측됩니다.

진단의 정확성과 효율성을 높이기 위한 기술의 역할은 무엇인가?

영상 진단 기술의 발전은 비침습적 관상동맥 영상 솔루션의 신뢰성과 채택률을 높이는 데 핵심적인 역할을 하고 있습니다. CT 스캐너의 발전으로 촬영 속도가 빨라지고, 피폭선량이 감소하고, 공간 해상도가 향상됨에 따라 관상동맥 CT 앵글 촬영은 관상동맥 질환이 의심되는 환자를 평가할 수 있는 최전방 툴이 되었습니다. 동시에 심장 MRI는 환자에게 전리방사선을 조사하지 않고 심근의 관류, 생존력, 섬유화를 평가하기 위해 널리 사용되고 있습니다. 인공지능과 머신러닝이 영상 진단 플랫폼에 통합되면서 진단 정확도가 더욱 향상되었고, 대규모 데이터 분석에 기반한 협착 자동 감지, 플라크 특성화, 위험도 계층화가 가능해졌습니다. 또한 이러한 기술은 워크플로우를 간소화하여 영상의학과 전문의와 심장 전문의가 보다 빠르고 일관성 있게 스캔을 해석할 수 있도록 돕습니다. 듀얼 에너지 CT와 광자 계수 CT는 차세대 영상 기술 혁신으로, 조직 대비를 강화하고 관상동맥의 시각화를 방해하는 아티팩트를 감소시켜 관상동맥의 시각화를 방해하는 아티팩트를 감소시킵니다. 또한 스트레스 CMR이나 PET 스캔과 같은 기능적 영상 진단 기술은 심근 혈류 및 관류 장애에 대한 매우 정확한 인사이트를 제공하여 혈행 재건술의 필요성을 판단하는 데 중요한 역할을 합니다. 전자의무기록(EHR) 및 클라우드 기반 공유 시스템과의 상호운용성을 통해 원활한 데이터 통합이 가능해졌으며, 시설 간 세컨드 오피니언 상담도 가능해졌습니다. 이러한 기술적 도약은 단순히 정확도를 향상시킬 뿐만 아니라, 보다 빠르고, 환자 친화적이며, 고도로 개인화된 진단 경로를 재구성하고 있습니다.

임상 관행의 변화와 환자 선호도가 채택을 촉진하고 있는가?

비침습적 관상동맥 영상 촬영에 대한 수요 증가에는 환자의 기대치 변화와 함께 임상적 관행의 변화가 매우 중요한 역할을 하고 있습니다. 순환기내과 전문의와 일반의들은 안정된 흉통과 위험도 평가를 위한 1차 진단으로 비침습적 영상 진단을 추천하는 경향이 있으며, 특히 그 임상적 유효성을 지원하는 근거가 점점 더 많아지고 있습니다. 미국심장학회(American College of Cardiology)와 유럽심장학회(European Society of Cardiology)와 같은 유명한 단체의 가이드라인은 불필요한 침습적 시술과 그에 따른 합병증을 줄일 수 있다는 것을 증명하고 있습니다. 비침습적 시술을 지지하는 경향이 강해지고 있습니다. 환자 입장에서는 편의성, 불안감 감소, 빠른 회복에 대한 요구로 인해 비침습적인 외래 기반 진단을 선호하는 경향이 그 어느 때보다 강해지고 있습니다. 이는 침습적 검사가 더 높은 위험을 초래하는 고령자나 여러 합병증을 가진 환자에서 특히 관련이 있습니다. 또한 비침습적 대안은 원격의료 및 원격의료 모델에서 보다 확장성이 뛰어나며, 진단 서비스를 지방이나 의료 서비스가 부족한 지역의 환자들에게도 확대할 수 있습니다. 또한 당뇨병, 비만, 고혈압 등 생활습관 관련 위험인자 증가로 인해 특히 무증상 고위험군에서는 더 일찍, 더 자주 심혈관 검진을 받을 필요가 있습니다. 병원과 영상 진단센터들은 이러한 변화에 대응하기 위해 멀티모달리티 이미징 스위트에 투자하고, 외래 진단을 위한 순환기과 서비스 라인을 확장하는 등 다양한 노력을 기울이고 있습니다. 이러한 추세는 모두 의료 프로바이더의 전략과 환자의 사고방식이 크게 변화하고 있으며, 전 세계 의료 시스템에서 비침습적 관상동맥 이미징이 장기적으로 채택될 수 있도록 촉진하고 있습니다.

비침습적 관상동맥 영상 시장의 급성장 원동력은?

비침습적 관상동맥 영상 시장의 성장은 기술 혁신, 임상 경로의 진화, 의료 서비스 제공 시스템의 변화 등 여러 가지 요인에 의해 주도되고 있습니다. 가장 큰 원동력 중 하나는 침습적 시술 특유의 위험 없이 관상동맥의 해부학적 구조와 기능을 실시간으로 상세하게 시각화할 수 있는 이미징 플랫폼의 발전입니다. 스캐너의 속도, 이미지 해상도, 후처리 소프트웨어의 지속적인 개선으로 이러한 양식의 임상적 유용성이 크게 확대되었습니다. 최종사용자 측면에서 의료 서비스 프로바이더는 비침습적 영상 진단에 대한 의존도를 높여 환자를 효율적으로 분류하고 불필요한 심장 카테터 삽입을 줄이며 전반적인 치료의 질을 향상시키기 위해 비침습적 영상 진단에 대한 의존도를 높이고 있습니다. 이러한 변화는 특히 CCTA나 심장 MRI와 같은 비침습적 시술의 진단적, 예후적 가치를 인정하는 업데이트된 임상 가이드라인에 의해 지원되고 있습니다. 소비자 행동도 시장 역학에 영향을 미치고 있으며, 보다 안전한 진단 옵션을 적극적으로 찾고 예방 검진 프로그램에 참여하는 환자가 증가하고 있습니다. 또한 AI 지원 영상 진단 툴의 출현으로 생산성이 향상되고, 진단의 편차가 줄어들고, 일반 개업의나 비전문가도 고급 해석을 보다 쉽게 이용할 수 있게 되었습니다. 병원 네트워크와 영상 진단센터도 자원 활용을 최적화하고, 진단 일정을 단축하고, 환자 처리량을 개선하기 위해 이러한 기술을 도입하고 있습니다. 이러한 변화에 맞추어 많은 국가의 진료비 보상 체계가 점차 변화하고 있으며, 비침습적 영상 진단이 의료 서비스 프로바이더에게 경제적으로도 실현 가능한 수준으로 변화하고 있습니다. 마지막으로 인구 고령화, 좌식 생활습관, 식생활의 변화 등을 배경으로 선진국과 개발도상국을 막론하고 심혈관 질환의 발병률이 증가함에 따라 정확한 조기 진단 툴에 대한 수요가 꾸준히 증가하고 있습니다. 이러한 요인들이 복합적으로 작용하여 비침습적 관상동맥 이미징 시장의 급격한 성장에 박차를 가하고 있습니다.

부문

모달리티(심장 초음파, 심장 컴퓨터 단층촬영, 심장 자기공명영상, 방사성 핵종 심장 영상); 최종사용자(병원 최종사용자, 영상 진단 센터 최종사용자, 연구기관 최종사용자)

조사 대상 기업의 예

  • Abbott Laboratories
  • Arterys Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Esaote S.p.A.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • HeartFlow, Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • NeoSoft LLC
  • Neusoft Corporation
  • Philips Healthcare
  • Pie Medical Imaging
  • Positron Corporation
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers
  • Viatronix, Inc.

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 큐레이트된 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.18

Global Non-invasive Coronary Imaging Market to Reach US$530.6 Million by 2030

The global market for Non-invasive Coronary Imaging estimated at US$392.3 Million in the year 2024, is expected to reach US$530.6 Million by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Echocardiography, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$204.8 Million by the end of the analysis period. Growth in the Cardiac Computed Tomography segment is estimated at 6.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$106.9 Million While China is Forecast to Grow at 7.9% CAGR

The Non-invasive Coronary Imaging market in the U.S. is estimated at US$106.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$104.0 Million by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Global Non-Invasive Coronary Imaging Market - Key Trends & Drivers Summarized

How Is Non-Invasive Coronary Imaging Changing the Game in Cardiovascular Diagnosis?

Non-invasive coronary imaging is revolutionizing the landscape of cardiovascular diagnostics, offering clinicians safer, faster, and highly accurate methods to assess coronary artery disease (CAD) without the need for catheter-based procedures. Traditional coronary angiography, while effective, involves significant patient risk due to its invasive nature, including potential vascular injury, allergic reactions to contrast agents, and post-procedure recovery time. In contrast, non-invasive techniques such as coronary computed tomography angiography (CCTA), cardiac magnetic resonance imaging (CMR), and positron emission tomography (PET) are enabling high-resolution visualization of coronary vessels with reduced procedural risk. These technologies have become pivotal in detecting plaque buildup, assessing stenosis, and evaluating overall heart function. Patients benefit significantly from quicker turnaround times, minimal discomfort, and reduced hospital stays, while physicians gain access to detailed anatomical and functional data that supports more informed treatment decisions. Additionally, the ability of non-invasive imaging tools to detect subclinical atherosclerosis-well before symptoms appear-has made them indispensable in preventive cardiology. The integration of functional assessment through methods like fractional flow reserve derived from CT (FFR-CT) is also bridging the gap between anatomical imaging and physiological insight, allowing more accurate identification of ischemia-causing lesions. As cardiovascular disease remains the leading cause of mortality globally, the role of non-invasive imaging in early detection and disease management is only expected to grow stronger.

What Role Does Technology Play in Elevating Diagnostic Accuracy and Efficiency?

Advancements in imaging technologies are central to the growing reliability and adoption of non-invasive coronary imaging solutions. The evolution of CT scanners-marked by faster acquisition speeds, reduced radiation exposure, and improved spatial resolution-has made coronary CT angiography a frontline tool for evaluating patients with suspected coronary artery disease. Simultaneously, cardiac MRI is becoming more widely used to assess myocardial perfusion, viability, and fibrosis without exposing patients to ionizing radiation. The integration of artificial intelligence and machine learning into imaging platforms is further amplifying diagnostic accuracy, allowing for automated detection of stenosis, plaque characterization, and risk stratification based on large-scale data analysis. These technologies also streamline workflow, enabling radiologists and cardiologists to interpret scans faster and with greater consistency. Dual-energy CT and photon-counting CT are the next generation of imaging innovations, providing enhanced tissue contrast and reducing artifacts that previously hindered coronary visualization. Moreover, functional imaging techniques such as stress CMR and PET scans now offer highly precise insights into myocardial blood flow and perfusion defects, which are critical for determining the need for revascularization procedures. Interoperability with electronic health records (EHRs) and cloud-based sharing systems allows for seamless data integration and second-opinion consultations across institutions. These technological leaps are not just improving accuracy-they're reshaping the diagnostic pathway to be faster, more patient-friendly, and highly personalized.

Are Shifting Clinical Practices and Patient Preferences Driving Adoption?

Changing clinical practices, along with evolving patient expectations, are playing a pivotal role in the increased demand for non-invasive coronary imaging modalities. Cardiologists and general practitioners are now more inclined to recommend non-invasive imaging as a first-line diagnostic option for stable chest pain and risk assessment, especially with the growing body of evidence supporting its clinical efficacy. Guidelines from prominent organizations such as the American College of Cardiology and the European Society of Cardiology increasingly favor non-invasive modalities due to their proven ability to reduce unnecessary invasive procedures and associated complications. From the patient's perspective, the preference for non-invasive, outpatient-based diagnostics is stronger than ever, driven by a desire for convenience, lower anxiety levels, and quicker recovery. This is particularly relevant in older populations and those with multiple comorbidities, where invasive testing poses higher risks. Non-invasive options are also more scalable in telemedicine and remote healthcare models, allowing diagnostic services to be extended to patients in rural and underserved areas. Furthermore, the rising prevalence of lifestyle-related risk factors such as diabetes, obesity, and hypertension is prompting earlier and more frequent cardiovascular screening, especially in asymptomatic high-risk groups. Hospitals and imaging centers are responding to these shifts by investing in multi-modality imaging suites and expanding cardiology service lines to accommodate outpatient diagnostics. All these trends point toward a significant shift in both provider strategy and patient mindset, reinforcing the long-term adoption of non-invasive coronary imaging across healthcare systems worldwide.

What’s Powering the Rapid Growth of the Non-Invasive Coronary Imaging Market?

The growth in the non-invasive coronary imaging market is driven by several factors spanning technological innovation, evolving clinical pathways, and shifts in healthcare delivery systems. One of the foremost drivers is the advancement of imaging platforms capable of delivering detailed, real-time visualization of coronary anatomy and function without the inherent risks of invasive procedures. Continuous improvements in scanner speed, image resolution, and post-processing software have significantly broadened the clinical utility of these modalities. On the end-user side, healthcare providers are increasingly relying on non-invasive imaging to triage patients efficiently, reduce unnecessary cardiac catheterizations, and improve overall care quality. This shift is supported by updated clinical guidelines that recognize the diagnostic and prognostic value of non-invasive techniques, particularly CCTA and cardiac MRI. Consumer behavior is also influencing market dynamics, with a growing number of patients actively seeking safer diagnostic options and participating in preventive health screening programs. Additionally, the emergence of AI-enabled imaging tools has enhanced productivity, reduced diagnostic variability, and made advanced interpretation more accessible to general practitioners and non-specialist providers. Hospital networks and imaging centers are also embracing these technologies to optimize resource utilization, shorten diagnostic timelines, and improve patient throughput. Reimbursement structures in many countries are gradually aligning with these shifts, making non-invasive imaging financially viable for providers. Finally, rising cardiovascular disease prevalence across both developed and developing nations-driven by aging populations, sedentary lifestyles, and poor dietary habits-is creating a robust and ongoing demand for accurate, early-stage diagnostic tools. Together, these factors are fueling the rapid global expansion of the non-invasive coronary imaging market.

SCOPE OF STUDY:

The report analyzes the Non-invasive Coronary Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Modality (Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging, Radionuclide Cardiac Imaging); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Arterys Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Circle Cardiovascular Imaging Inc.
  • Esaote S.p.A.
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • HeartFlow, Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • NeoSoft LLC
  • Neusoft Corporation
  • Philips Healthcare
  • Pie Medical Imaging
  • Positron Corporation
  • Samsung Medison Co., Ltd.
  • Siemens Healthineers
  • Viatronix, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Non-invasive Coronary Imaging - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Shift Toward Early Cardiovascular Risk Detection Throws the Spotlight on Non-Invasive Imaging Modalities
    • Increased Patient Preference for Radiation-Free and Painless Diagnostics Strengthens the Business Case for Non-Invasive Imaging
    • Surging Global Burden of Coronary Artery Disease Propels Growth Across Diagnostic Ecosystems
    • Integration of Functional Imaging and Anatomical Mapping Expands the Addressable Market Opportunity in Complex Cases
    • Widespread Adoption of AI-Enhanced Image Interpretation Drives Diagnostic Accuracy and Workflow Efficiency
    • Advancements in CT and MRI Technologies Accelerate Demand for High-Resolution Non-Invasive Cardiac Imaging
    • Rising Utilization in Preventive Health Programs Spurs Growth in Asymptomatic and At-Risk Populations
    • Emergence of Hybrid Imaging Platforms Strengthens Clinical Relevance and Adoption Across Hospital Systems
    • Growth in Outpatient Cardiology Services and Diagnostic Clinics Sustains Market Expansion
    • Remote Diagnostics and Teleradiology Integration Opens New Avenues in Underserved and Rural Markets
    • Increasing Emphasis on Patient Safety and Procedure Efficiency Spurs Transition from Invasive to Non-Invasive Modalities
    • Consumer Awareness and Digital Health Trends Generate Demand for Non-Invasive, Personalized Cardiac Assessments
    • Infrastructure Modernization and Cardiac Center Investments in Emerging Economies Fuel Market Penetration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Non-invasive Coronary Imaging Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Non-invasive Coronary Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Echocardiography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Echocardiography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cardiac Computed Tomography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cardiac Computed Tomography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cardiac Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cardiac Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cardiac Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Radionuclide Cardiac Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Radionuclide Cardiac Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Radionuclide Cardiac Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Imaging Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostic Imaging Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Non-invasive Coronary Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Non-invasive Coronary Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Non-invasive Coronary Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Non-invasive Coronary Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Non-invasive Coronary Imaging by Modality - Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Non-invasive Coronary Imaging by Modality - Percentage Breakdown of Value Sales for Echocardiography, Cardiac Computed Tomography, Cardiac Magnetic Resonance Imaging and Radionuclide Cardiac Imaging for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Non-invasive Coronary Imaging by End-Use - Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Non-invasive Coronary Imaging by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Imaging Centers End-Use and Research Institutes End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제